1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO RGD:735910 6480464 o, p'-DDT results in decreased expression of CX3CL1 mRNA CTD PMID:18204070 17alpha-ethynylestradiol affects expression ISO RGD:731691 6480464 Ethinyl Estradiol affects the expression of CX3CL1 mRNA CTD PMID:17555576 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CX3CL1 mRNA CTD PMID:26496021 17beta-estradiol multiple interactions ISO RGD:735910 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of CX3CL1 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731691 6480464 Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CX3CL1 mRNA], Tetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CX3CL1 mRNA] CTD PMID:15667827 , PMID:16054899 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:735910 6480464 Tetrachlorodibenzodioxin results in decreased expression of CX3CL1 mRNA CTD PMID:28351761 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CX3CL1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735910 6480464 Tetrachlorodibenzodioxin affects the expression of CX3CL1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731691 6480464 Tetrachlorodibenzodioxin results in decreased expression of CX3CL1 mRNA CTD PMID:19933214 2,3-dimethoxynaphthalene-1,4-dione decreases expression ISO RGD:735910 6480464 2 more ... CTD PMID:17547211 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:731691 6480464 Trinitrobenzenesulfonic Acid results in increased expression of CX3CL1 mRNA CTD PMID:15973123 2,4-diaminotoluene increases expression ISO RGD:731691 6480464 2, 4-diaminotoluene results in increased expression of CX3CL1 mRNA CTD PMID:20713471 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of CX3CL1 mRNA CTD PMID:17187413 2-methylcholine affects expression ISO RGD:735910 6480464 beta-methylcholine affects the expression of CX3CL1 mRNA CTD PMID:21179406 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:19692669 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:735910 6480464 3 more ... CTD PMID:28351761 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,4-dichloroaniline increases expression EXP 6480464 3, 4-dichloroaniline results in increased expression of CX3CL1 mRNA CTD PMID:24172598 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:731691 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CX3CL1 mRNA more ... CTD PMID:16054899 , PMID:23503329 3-methylcholanthrene increases expression ISO RGD:731691 6480464 Methylcholanthrene results in increased expression of CX3CL1 mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol decreases expression ISO RGD:731691 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of CX3CL1 mRNA CTD PMID:30951980 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO RGD:731691 6480464 Oxazolone results in decreased expression of CX3CL1 mRNA CTD PMID:21404309 4-hydroxyphenyl retinamide increases expression ISO RGD:731691 6480464 Fenretinide results in increased expression of CX3CL1 mRNA CTD PMID:28973697 8-Br-cAMP increases expression ISO RGD:735910 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CX3CL1 mRNA CTD PMID:22079614 acetylsalicylic acid multiple interactions ISO RGD:735910 6480464 Aspirin inhibits the reaction [TNF results in increased expression of CX3CL1 mRNA], Aspirin inhibits the reaction [TNF results in increased expression of CX3CL1 protein] CTD PMID:19493461 acetylsalicylic acid decreases expression ISO RGD:731691 6480464 Aspirin results in decreased expression of CX3CL1 mRNA, Aspirin results in decreased expression of CX3CL1 protein CTD PMID:19997773 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of CX3CL1 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:731691 6480464 Acrylamide results in decreased expression of CX3CL1 mRNA CTD PMID:29261810 aflatoxin B1 affects expression ISO RGD:735910 6480464 Aflatoxin B1 affects the expression of CX3CL1 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CX3CL1 mRNA CTD PMID:23630614 , PMID:25378103 aldehydo-D-glucose increases expression ISO RGD:735910 6480464 Glucose results in increased expression of CX3CL1 mRNA, Glucose results in increased expression of CX3CL1 protein CTD PMID:19132243 aldehydo-D-glucose multiple interactions ISO RGD:735910 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA] more ... CTD PMID:19132243 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of CX3CL1 mRNA CTD PMID:20488242 all-trans-retinoic acid decreases expression ISO RGD:735910 6480464 Tretinoin results in decreased expression of CX3CL1 mRNA CTD PMID:23724009 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CX3CL1 mRNA CTD PMID:16483693 aripiprazole multiple interactions ISO RGD:735910 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of CX3CL1 mRNA CTD PMID:31476115 arsenite(3-) multiple interactions ISO RGD:731691 6480464 TRP53 protein affects the reaction [arsenite results in decreased expression of CX3CL1 mRNA] CTD PMID:18929588 arsenite(3-) decreases expression ISO RGD:731691 6480464 arsenite results in decreased expression of CX3CL1 mRNA CTD PMID:18929588 arsenous acid decreases expression ISO RGD:735910 6480464 Arsenic Trioxide results in decreased expression of CX3CL1 mRNA CTD PMID:17547211 asperentin increases expression ISO RGD:731691 6480464 cladosporin results in increased expression of CX3CL1 mRNA CTD PMID:19818335 benzo[a]pyrene decreases expression ISO RGD:731691 6480464 Benzo(a)pyrene results in decreased expression of CX3CL1 mRNA CTD PMID:21569818 benzo[a]pyrene decreases expression ISO RGD:735910 6480464 Benzo(a)pyrene results in decreased expression of CX3CL1 mRNA CTD PMID:28351761 benzo[a]pyrene increases expression ISO RGD:731691 6480464 Benzo(a)pyrene results in increased expression of CX3CL1 mRNA CTD PMID:22228805 benzo[b]fluoranthene affects expression ISO RGD:731691 6480464 benzo(b)fluoranthene affects the expression of CX3CL1 mRNA CTD PMID:26377693 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CX3CL1 mRNA CTD PMID:18164116 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CX3CL1 mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:731691 6480464 bisphenol A results in increased expression of CX3CL1 mRNA CTD PMID:29248573 bisphenol A affects expression ISO RGD:735910 6480464 bisphenol A affects the expression of CX3CL1 mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CX3CL1 mRNA CTD PMID:25181051 bisphenol F decreases expression ISO RGD:731691 6480464 bisphenol F results in decreased expression of CX3CL1 mRNA CTD PMID:30951980 capsaicin affects expression EXP 6480464 Capsaicin affects the expression of CX3CL1 protein CTD PMID:22150557 capsaicin multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein] more ... CTD PMID:22150557 carbon nanotube decreases expression ISO RGD:731691 6480464 Nanotubes, Carbon analog results in decreased expression of CX3CL1 mRNA, Nanotubes, Carbon results in decreased expression of CX3CL1 mRNA CTD PMID:25554681 ceric oxide increases expression EXP 6480464 ceric oxide results in increased expression of CX3CL1 mRNA CTD PMID:29463257 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of CX3CL1 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:731691 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of CX3CL1 protein, PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in increased expression of CX3CL1 protein] CTD PMID:29246445 chromium atom decreases expression ISO RGD:735910 6480464 Chromium results in decreased expression of CX3CL1 mRNA CTD PMID:17547211 ciguatoxin CTX1B affects expression ISO RGD:731691 6480464 Ciguatoxins affects the expression of CX3CL1 mRNA CTD PMID:18353800 clofibrate multiple interactions ISO RGD:735910 6480464 Clofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA], Clofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 protein] CTD PMID:19132243 cobalt atom multiple interactions ISO RGD:731691 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CX3CL1 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CX3CL1 mRNA] CTD PMID:23503329 cocaine increases expression EXP 6480464 Cocaine results in increased expression of CX3CL1 mRNA CTD PMID:16076954 copper(II) sulfate decreases expression ISO RGD:735910 6480464 Copper Sulfate results in decreased expression of CX3CL1 mRNA CTD PMID:19549813 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of CX3CL1 protein CTD PMID:16651033 cyclosporin A increases expression ISO RGD:735910 6480464 Cyclosporine results in increased expression of CX3CL1 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:735910 6480464 Cyclosporine results in decreased expression of CX3CL1 mRNA CTD PMID:25562108 D-glucose multiple interactions ISO RGD:735910 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA] more ... CTD PMID:19132243 D-glucose increases expression ISO RGD:735910 6480464 Glucose results in increased expression of CX3CL1 mRNA, Glucose results in increased expression of CX3CL1 protein CTD PMID:19132243 deoxynivalenol increases expression ISO RGD:735910 6480464 deoxynivalenol results in increased expression of CX3CL1 mRNA CTD PMID:22846391 dexamethasone multiple interactions ISO RGD:731691 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CX3CL1 mRNA more ... CTD PMID:16054899 , PMID:23503329 dexamethasone decreases expression ISO RGD:731691 6480464 Dexamethasone results in decreased expression of CX3CL1 mRNA CTD PMID:22733784 dexamethasone increases expression ISO RGD:731691 6480464 Dexamethasone results in increased expression of CX3CL1 mRNA CTD PMID:21041162 diarsenic trioxide decreases expression ISO RGD:735910 6480464 Arsenic Trioxide results in decreased expression of CX3CL1 mRNA CTD PMID:17547211 dibenz[a,h]anthracene decreases expression ISO RGD:731691 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CX3CL1 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:731691 6480464 Dibutyl Phthalate results in increased expression of CX3CL1 mRNA CTD PMID:21266533 dioxygen increases response to substance ISO RGD:735910 6480464 Oxygen deficiency results in increased susceptibility to CX3CL1 protein CTD PMID:17476338 diuron increases expression EXP 6480464 Diuron metabolite results in increased expression of CX3CL1 mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO RGD:735910 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CX3CL1 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:735910 6480464 Doxorubicin results in decreased expression of CX3CL1 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CX3CL1 mRNA CTD PMID:29391264 enzacamene increases expression ISO RGD:735910 6480464 enzacamene results in increased expression of CX3CL1 mRNA CTD PMID:30597193 ethanol affects expression EXP 6480464 Ethanol affects the expression of CX3CL1 mRNA CTD PMID:11772933 ethanol multiple interactions ISO RGD:731691 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CX3CL1 mRNA, Ethanol affects the expression of and affects the splicing of CX3CL1 mRNA CTD PMID:30319688 , PMID:30517762 fenofibrate multiple interactions ISO RGD:735910 6480464 Fenofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA], Fenofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 protein] CTD PMID:19132243 furan decreases methylation EXP 6480464 furan results in decreased methylation of CX3CL1 gene CTD PMID:27387713 furan increases expression EXP 6480464 furan results in increased expression of CX3CL1 mRNA CTD PMID:27387713 glucose multiple interactions ISO RGD:735910 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA] more ... CTD PMID:19132243 glucose increases expression ISO RGD:735910 6480464 Glucose results in increased expression of CX3CL1 mRNA, Glucose results in increased expression of CX3CL1 protein CTD PMID:19132243 hydrogen peroxide multiple interactions EXP 6480464 CX3CL1 inhibits the reaction [Vehicle Emissions results in increased abundance of Hydrogen Peroxide] CTD PMID:21561831 ibuprofen affects expression ISO RGD:735910 6480464 Ibuprofen affects the expression of CX3CL1 mRNA CTD PMID:17070997 ketamine increases expression EXP 6480464 Ketamine results in increased expression of CX3CL1 mRNA CTD PMID:20080153 lead diacetate increases secretion EXP 6480464 lead acetate results in increased secretion of CX3CL1 protein CTD PMID:17047031 lead(0) affects expression ISO RGD:735910 6480464 Lead affects the expression of CX3CL1 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:735910 6480464 Lead affects the expression of CX3CL1 mRNA CTD PMID:28903495 lipopolysaccharide multiple interactions ISO RGD:731691 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of CX3CL1 mRNA] CTD PMID:26582142 lipopolysaccharide increases expression ISO RGD:731691 6480464 Lipopolysaccharides results in increased expression of CX3CL1 mRNA CTD PMID:26582142 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of CX3CL1 mRNA CTD PMID:28801915 mechlorethamine increases expression EXP 6480464 Mechlorethamine results in increased expression of CX3CL1 mRNA CTD PMID:26273949 methadone increases secretion EXP 6480464 Methadone results in increased secretion of CX3CL1 protein CTD PMID:20178837 methylmercury chloride decreases expression ISO RGD:731691 6480464 methylmercuric chloride results in decreased expression of CX3CL1 mRNA CTD PMID:29261810 mifepristone increases expression ISO RGD:735910 6480464 Mifepristone results in increased expression of CX3CL1 mRNA CTD PMID:17584828 morphine affects response to substance EXP 6480464 CX3CL1 protein affects the susceptibility to Morphine CTD PMID:15317861 morphine increases secretion EXP 6480464 Morphine results in increased secretion of CX3CL1 protein CTD PMID:20178837 mycophenolic acid increases expression ISO RGD:731691 6480464 Mycophenolic Acid results in increased expression of CX3CL1 mRNA CTD PMID:19818335 mycotoxin increases expression ISO RGD:731691 6480464 Mycotoxins results in increased expression of CX3CL1 mRNA CTD PMID:19818335 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:735910 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [TNF protein results in increased expression of CX3CL1 mRNA] CTD PMID:11698246 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CX3CL1 mRNA, [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CX3CL1 mRNA CTD PMID:18164116 , PMID:23830814 N-nitrosodimethylamine decreases expression ISO RGD:735910 6480464 Dimethylnitrosamine results in decreased expression of CX3CL1 mRNA CTD PMID:17547211 naproxen multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein], Naproxen inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein] CTD PMID:22150557 neoechinulin A increases expression ISO RGD:731691 6480464 neoechinulin A results in increased expression of CX3CL1 mRNA CTD PMID:19818335 nickel atom affects expression ISO RGD:735910 6480464 Nickel affects the expression of CX3CL1 mRNA CTD PMID:14575637 nickel atom multiple interactions ISO RGD:731691 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CX3CL1 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CX3CL1 mRNA] CTD PMID:23503329 nickel atom multiple interactions ISO RGD:735910 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of CX3CL1 mRNA] CTD PMID:14575637 nickel dichloride increases expression ISO RGD:735910 6480464 nickel chloride results in increased expression of CX3CL1 mRNA CTD PMID:17312168 ozone decreases expression EXP 6480464 Ozone results in decreased expression of CX3CL1 mRNA CTD PMID:16716893 ozone increases expression ISO RGD:735910 6480464 Ozone results in increased expression of CX3CL1 mRNA CTD PMID:31476115 ozone multiple interactions ISO RGD:735910 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of CX3CL1 mRNA CTD PMID:31476115 p-cresol multiple interactions ISO RGD:735910 6480464 4-cresol inhibits the reaction [IL1B protein results in increased expression of CX3CL1 protein] CTD PMID:16954166 panobinostat multiple interactions ISO RGD:735910 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CX3CL1 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:735910 6480464 panobinostat results in increased expression of CX3CL1 mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:731691 6480464 Acetaminophen affects the expression of CX3CL1 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:735910 6480464 Acetaminophen results in increased expression of CX3CL1 mRNA CTD PMID:29067470 paracetamol increases expression ISO RGD:731691 6480464 Acetaminophen results in increased expression of CX3CL1 protein CTD PMID:29246445 paracetamol multiple interactions ISO RGD:731691 6480464 [MST1R protein mutant form co-treated with Acetaminophen] results in increased expression of CX3CL1 mRNA CTD PMID:22575169 phenobarbital affects expression ISO RGD:735910 6480464 Phenobarbital affects the expression of CX3CL1 mRNA CTD PMID:19159669 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of CX3CL1 mRNA CTD PMID:20345932 phorbol 13-acetate 12-myristate decreases expression ISO RGD:735910 6480464 Tetradecanoylphorbol Acetate results in decreased expression of CX3CL1 mRNA CTD PMID:19850645 potassium dichromate decreases expression ISO RGD:735910 6480464 Potassium Dichromate results in decreased expression of CX3CL1 mRNA CTD PMID:17547211 progesterone multiple interactions ISO RGD:735910 6480464 CX3CL1 protein promotes the reaction [CGB3 protein results in increased abundance of Progesterone] CTD PMID:18292196 progesterone decreases expression ISO RGD:731691 6480464 Progesterone results in decreased expression of CX3CL1 mRNA CTD PMID:22238285 quercetin decreases expression ISO RGD:735910 6480464 Quercetin results in decreased expression of CX3CL1 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:735910 6480464 Resveratrol inhibits the reaction [TNF protein results in increased expression of CX3CL1 mRNA], Resveratrol inhibits the reaction [TNF protein results in increased expression of CX3CL1 protein] CTD PMID:16614140 resveratrol decreases expression ISO RGD:735910 6480464 resveratrol results in decreased expression of CX3CL1 mRNA CTD PMID:23224687 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [TNF protein results in increased expression of CX3CL1 protein] CTD PMID:16614140 rofecoxib affects expression ISO RGD:735910 6480464 rofecoxib affects the expression of CX3CL1 mRNA CTD PMID:17070997 rutin decreases expression EXP 6480464 Rutin results in decreased expression of CX3CL1 mRNA CTD PMID:28693884 SB 203580 multiple interactions ISO RGD:735910 6480464 SB 203580 inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA], SB 203580 inhibits the reaction [Glucose results in increased expression of CX3CL1 protein] CTD PMID:19132243 SB 431542 multiple interactions ISO RGD:735910 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CX3CL1 mRNA CTD PMID:27188386 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CX3CL1 mRNA CTD PMID:22431001 silver atom increases secretion EXP 6480464 Silver results in increased secretion of CX3CL1 protein CTD PMID:26702581 silver(0) increases secretion EXP 6480464 Silver results in increased secretion of CX3CL1 protein CTD PMID:26702581 sodium arsenite decreases expression ISO RGD:731691 6480464 sodium arsenite results in decreased expression of CX3CL1 mRNA CTD PMID:21911445 sodium arsenite increases expression ISO RGD:735910 6480464 sodium arsenite results in increased expression of CX3CL1 mRNA CTD PMID:29301061 sterigmatocystin increases expression ISO RGD:731691 6480464 Sterigmatocystin results in increased expression of CX3CL1 mRNA CTD PMID:19818335 sumatriptan multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein], Sumatriptan inhibits the reaction [Capsaicin affects the expression of CX3CL1 protein] CTD PMID:22150557 sunitinib decreases expression ISO RGD:735910 6480464 Sunitinib results in decreased expression of CX3CL1 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:731691 6480464 Tamoxifen affects the expression of CX3CL1 mRNA CTD PMID:17555576 tetrachloromethane multiple interactions ISO RGD:731691 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CX3CL1 mRNA CTD PMID:30517762 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CX3CL1 mRNA CTD PMID:23830814 titanium dioxide decreases expression ISO RGD:731691 6480464 titanium dioxide results in decreased expression of CX3CL1 mRNA CTD PMID:27760801 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CX3CL1 mRNA CTD PMID:30012374 trichostatin A multiple interactions ISO RGD:735910 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of CX3CL1 mRNA] CTD PMID:14575637 triclosan increases expression ISO RGD:735910 6480464 Triclosan results in increased expression of CX3CL1 mRNA CTD PMID:30510588 tris(2-butoxyethyl) phosphate affects expression ISO RGD:735910 6480464 tris(2-butoxyethyl) phosphate affects the expression of CX3CL1 mRNA CTD PMID:29024780 valproic acid decreases expression ISO RGD:735910 6480464 Valproic Acid results in decreased expression of CX3CL1 mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:735910 6480464 Valproic Acid affects the expression of CX3CL1 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:735910 6480464 Valproic Acid results in increased expression of CX3CL1 mRNA CTD PMID:23179753 valproic acid increases expression ISO RGD:731691 6480464 Valproic Acid results in increased expression of CX3CL1 mRNA CTD PMID:21427059 valproic acid decreases expression ISO RGD:731691 6480464 Valproic Acid results in decreased expression of CX3CL1 mRNA CTD PMID:21427059 vancomycin decreases expression ISO RGD:731691 6480464 Vancomycin results in decreased expression of CX3CL1 mRNA CTD PMID:18930951 zinc atom multiple interactions ISO RGD:731691 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CX3CL1 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CX3CL1 mRNA] CTD PMID:23503329 zinc(0) multiple interactions ISO RGD:731691 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CX3CL1 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CX3CL1 mRNA] CTD PMID:23503329 zoledronic acid increases expression ISO RGD:735910 6480464 zoledronic acid results in increased expression of CX3CL1 mRNA CTD PMID:24714768
Biological Process aging IEP 9491804 RGD angiogenesis involved in wound healing ISO RGD:731691 1624291 MGI:MGI:3608773 (MGI:MGI:3772530 , PMID:18097059) RGD MGI:MGI:3772530 , PMID:18097059 angiogenesis involved in wound healing IEA UniProtKB:O35188 , ensembl:ENSMUSP000000342301600115 GO_REF:0000107 Ensembl GO_REF:0000107 autocrine signaling IGI UniProtKB:P35411 13673777 PMID:12729461 ARUK-UCL cell adhesion IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell adhesion ISO RGD:735910 1624291 UniProtKB:Q9Z0D9 (PMID:10187784) RGD PMID:10187784 cell chemotaxis ISO RGD:735910 1624291 (PMID:10415068) RGD PMID:10415068 cell-cell adhesion IDA 13673777 PMID:12729461 ARUK-UCL cellular response to interferon-gamma IBA MGI:MGI:98259 more ... 13792537 PMID:21873635 GO_Central cellular response to interleukin-1 IBA MGI:MGI:98259 more ... 13792537 PMID:21873635 GO_Central cellular response to tumor necrosis factor IBA MGI:MGI:98259 more ... 13792537 PMID:21873635 GO_Central chemokine-mediated signaling pathway IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 chemokine-mediated signaling pathway IBA PANTHER:PTN000245709 more ... 13792537 PMID:21873635 GO_Central chemokine-mediated signaling pathway ISO RGD:735910 1624291 (PMID:10415068) RGD PMID:10415068 chemotaxis IDA 727628 RGD chemotaxis IGI UniProtKB:P49238 13673766 PMID:16019082 ARUK-UCL chemotaxis ISO RGD:735910 1624291 (PMID:21829356), (PMID:23125415) RGD PMID:21829356 , PMID:23125415 cytokine-mediated signaling pathway ISO RGD:731691 1624291 (MGI:MGI:3833195, PMID:18971423) RGD MGI:MGI:3833195 , PMID:18971423 eosinophil chemotaxis IBA PANTHER:PTN001381485 more ... 13792537 PMID:21873635 GO_Central G protein-coupled receptor signaling pathway IGI UniProtKB:P35411 13673777 PMID:12729461 ARUK-UCL G protein-coupled receptor signaling pathway IBA PANTHER:PTN000245709 more ... 13792537 PMID:21873635 GO_Central immune response IEA InterPro:IPR001811 more ... 1600115 GO_REF:0000002 InterPro GO_REF:0000002 inflammatory response IBA MGI:MGI:108224 more ... 13792537 PMID:21873635 GO_Central inhibitory postsynaptic potential IMP 4891944 RGD integrin activation ISO RGD:735910 1624291 (PMID:23125415) RGD PMID:23125415 integrin activation ISS UniProtKB:P78423 1600115 GO_REF:0000024 UniProt GO_REF:0000024 integrin activation IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 leukocyte adhesive activation IEA InterPro:IPR008097 1600115 GO_REF:0000002 InterPro GO_REF:0000002 leukocyte migration involved in inflammatory response ISO RGD:735910 1624291 (PMID:23125415) RGD PMID:23125415 leukocyte migration involved in inflammatory response ISS UniProtKB:P78423 1600115 GO_REF:0000024 UniProt GO_REF:0000024 leukocyte migration involved in inflammatory response IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 lymphocyte chemotaxis ISO RGD:731691 1624291 (MGI:MGI:892218, PMID:9177350) RGD MGI:MGI:892218 , PMID:9177350 lymphocyte chemotaxis IBA MGI:MGI:1097153 more ... 13792537 PMID:21873635 GO_Central lymphocyte chemotaxis IEA UniProtKB:O35188 , ensembl:ENSMUSP000000342301600115 GO_REF:0000107 Ensembl GO_REF:0000107 macrophage chemotaxis ISO RGD:731691 1624291 (MGI:MGI:3703135, PMID:16272359) RGD MGI:MGI:3703135 , PMID:16272359 macrophage chemotaxis IEA UniProtKB:O35188 , ensembl:ENSMUSP000000342301600115 GO_REF:0000107 Ensembl GO_REF:0000107 microglial cell activation IDA 9491804 RGD microglial cell activation IDA 4892001 PMID:11870871 ARUK-UCL microglial cell proliferation IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 microglial cell proliferation ISO RGD:735910 1624291 (PMID:12125082) RGD PMID:12125082 monocyte chemotaxis IBA MGI:MGI:108224 more ... 13792537 PMID:21873635 GO_Central negative regulation of apoptotic process ISO RGD:735910 1624291 (PMID:24294368) RGD PMID:24294368 negative regulation of apoptotic signaling pathway ISO RGD:735910 1624291 UniProtKB:P35411 (PMID:10869418) RGD PMID:10869418 negative regulation of cell migration IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of cell migration ISO RGD:735910 1624291 (PMID:25435433) RGD PMID:25435433 negative regulation of cytokine secretion IMP 4892003 RGD negative regulation of extrinsic apoptotic signaling pathway in absence of ligand ISO RGD:731691 1624291 (MGI:MGI:3777228 more ... RGD MGI:MGI:3777228 more ... negative regulation of extrinsic apoptotic signaling pathway in absence of ligand IEA UniProtKB:O35188 , ensembl:ENSMUSP000000342301600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of glutamate receptor signaling pathway IDA 13673766 PMID:16019082 ARUK-UCL negative regulation of hippocampal neuron apoptotic process IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of hippocampal neuron apoptotic process ISO RGD:735910 1624291 UniProtKB:P35411 (PMID:10869418) RGD PMID:10869418 negative regulation of interleukin-1 alpha production IDA 13673772 PMID:19627440 ARUK-UCL negative regulation of microglial cell activation IDA 13673772 PMID:19627440 ARUK-UCL negative regulation of tumor necrosis factor secretion IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of tumor necrosis factor secretion ISO RGD:735910 1624291 (PMID:10652441) RGD PMID:10652441 negative regulation of vasoconstriction IDA 4891967 RGD neuron cellular homeostasis IDA 13673766 PMID:16019082 ARUK-UCL neutrophil chemotaxis ISO RGD:731691 1624291 (MGI:MGI:892218, PMID:9177350) RGD MGI:MGI:892218 , PMID:9177350 neutrophil chemotaxis IBA MGI:MGI:1097153 more ... 13792537 PMID:21873635 GO_Central neutrophil chemotaxis IEA UniProtKB:O35188 , ensembl:ENSMUSP000000342301600115 GO_REF:0000107 Ensembl GO_REF:0000107 platelet activation IMP 4891996 RGD positive chemotaxis IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive chemotaxis ISO RGD:735910 1624291 (PMID:10899174) RGD PMID:10899174 positive regulation of actin filament bundle assembly IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of actin filament bundle assembly ISO RGD:735910 1624291 UniProtKB:P35411 (PMID:10415068) RGD PMID:10415068 positive regulation of angiogenesis ISO RGD:731691 1624291 (MGI:MGI:3767138, PMID:17971299) RGD MGI:MGI:3767138 , PMID:17971299 positive regulation of angiogenesis IEA UniProtKB:O35188 , ensembl:ENSMUSP000000342301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of calcium-independent cell-cell adhesion ISO RGD:735910 1624291 (PMID:12714508) RGD PMID:12714508 positive regulation of calcium-independent cell-cell adhesion IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of cell adhesion IDA 4891970 RGD positive regulation of cell migration IDA 4891970 RGD positive regulation of cell population proliferation IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of cell population proliferation ISO RGD:735910 1624291 (PMID:24294368) RGD PMID:24294368 positive regulation of ERK1 and ERK2 cascade IBA PANTHER:PTN000245709 more ... 13792537 PMID:21873635 GO_Central positive regulation of GTPase activity IBA MGI:MGI:1346316 more ... 13792537 PMID:21873635 GO_Central positive regulation of I-kappaB kinase/NF-kappaB signaling IGI UniProtKB:P49797 13673777 PMID:12729461 ARUK-UCL positive regulation of I-kappaB phosphorylation IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of I-kappaB phosphorylation ISO RGD:735910 1624291 UniProtKB:P35411 (PMID:10869418) RGD PMID:10869418 positive regulation of inflammatory response ISO RGD:735910 1624291 (PMID:11777952) RGD PMID:11777952 positive regulation of inflammatory response IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of macrophage chemotaxis IMP 4891965 RGD positive regulation of MAPK cascade IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of MAPK cascade ISO RGD:735910 1624291 UniProtKB:Q01986 (PMID:10415068) RGD PMID:10415068 positive regulation of microglial cell migration IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of microglial cell migration ISO RGD:735910 1624291 (PMID:10415068) RGD PMID:10415068 positive regulation of neuroblast proliferation IDA 9491804 RGD positive regulation of neuron projection development IDA 8655547 PMID:23825416 ParkinsonsUK-UCL positive regulation of NF-kappaB transcription factor activity IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of NF-kappaB transcription factor activity ISO RGD:735910 1624291 UniProtKB:P35411 (PMID:10869418) RGD PMID:10869418 positive regulation of protein kinase B signaling IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of protein kinase B signaling ISO RGD:735910 1624291 UniProtKB:P35411 (PMID:10415068), (PMID:10869418) RGD PMID:10415068 , PMID:10869418 positive regulation of protein kinase B signaling IMP 13673777 PMID:12729461 ARUK-UCL positive regulation of release of sequestered calcium ion into cytosol IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of release of sequestered calcium ion into cytosol ISO RGD:735910 1624291 UniProtKB:P35411 (PMID:10415068), (PMID:10869418) RGD PMID:10415068 , PMID:10869418 positive regulation of smooth muscle cell proliferation IDA 4891893 RGD positive regulation of smooth muscle cell proliferation IDA 13673777 PMID:12729461 ARUK-UCL positive regulation of transcription by RNA polymerase II IDA 13673777 PMID:12729461 ARUK-UCL positive regulation of transforming growth factor beta1 production ISO RGD:731691 1624291 MGI:MGI:3608773 (MGI:MGI:3772530 , PMID:18097059) RGD MGI:MGI:3772530 , PMID:18097059 positive regulation of transforming growth factor beta1 production IEA UniProtKB:O35188 , ensembl:ENSMUSP000000342301600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of lipopolysaccharide-mediated signaling pathway IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of lipopolysaccharide-mediated signaling pathway ISO RGD:735910 1624291 (PMID:10652441) RGD PMID:10652441 response to hypoxia IEP 4891889 RGD response to ischemia IGI UniProtKB:P35411 13673875 PMID:12059974 ARUK-UCL wound healing ISO RGD:731691 1624291 MGI:MGI:3608773 (MGI:MGI:3772530 , PMID:18097059) RGD MGI:MGI:3772530 , PMID:18097059 Cellular Component cell IEA GO:0070050 1600115 GO_REF:0000108 GOC GO_REF:0000108 cell IEA GO:0051281 1600115 GO_REF:0000108 GOC GO_REF:0000108 cell body ISO RGD:731691 1624291 (MGI:MGI:6189307, PMID:12815711) RGD MGI:MGI:6189307 , PMID:12815711 cell projection IDA 4892001 RGD cell surface ISO RGD:731691 1624291 (MGI:MGI:892218, PMID:9177350) RGD MGI:MGI:892218 , PMID:9177350 cell surface IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell surface IEA UniProtKB:O35188 , ensembl:ENSMUSP000000342301600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell surface ISO RGD:735910 1624291 (PMID:12714508) RGD PMID:12714508 cytoplasm IDA 4891944 RGD extracellular region IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 extracellular region ISO RGD:735910 1624291 (PMID:10415068), (PMID:10899174), (PMID:12714508) RGD PMID:10415068 more ... extracellular region IDA 13673766 PMID:16019082 ARUK-UCL extracellular space IBA MGI:MGI:101878 more ... 13792537 PMID:21873635 GO_Central integral component of membrane ISO RGD:735910 1624291 (PMID:12714508) RGD PMID:12714508 integral component of membrane IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 membrane IDA 13673766 PMID:16019082 ARUK-UCL membrane ISO RGD:735910 1624291 (PMID:10899174) RGD PMID:10899174 neuron projection IDA 1358720 PMID:15341587 ARUK-UCL neuron projection ISO RGD:731691 1624291 (MGI:MGI:6189307, PMID:12815711) RGD MGI:MGI:6189307 , PMID:12815711 neuron projection IEA UniProtKB:O35188 , ensembl:ENSMUSP000000342301600115 GO_REF:0000107 Ensembl GO_REF:0000107 neuronal cell body IDA 1358720 PMID:15341587 ARUK-UCL neuronal cell body ISO RGD:731691 1624291 (MGI:MGI:6189307, PMID:12815711) RGD MGI:MGI:6189307 , PMID:12815711 neuronal cell body IDA 13673875 PMID:12059974 ARUK-UCL neuronal cell body IEA UniProtKB:O35188 , ensembl:ENSMUSP000000342301600115 GO_REF:0000107 Ensembl GO_REF:0000107 perinuclear region of cytoplasm IDA 4892001 RGD plasma membrane IEA UniProtKB:O35188 , ensembl:ENSMUSP000000342301600115 GO_REF:0000107 Ensembl GO_REF:0000107 plasma membrane ISO RGD:731691 1624291 (MGI:MGI:6258315, PMID:28612258) RGD MGI:MGI:6258315 , PMID:28612258 postsynapse IEA GO:0060080 1600115 GO_REF:0000108 GOC GO_REF:0000108 Molecular Function CCR chemokine receptor binding IBA MGI:MGI:108224 more ... 13792537 PMID:21873635 GO_Central chemoattractant activity IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 chemoattractant activity ISO RGD:735910 1624291 (PMID:10899174) RGD PMID:10899174 chemokine activity IDA 727628 RGD chemokine activity IBA MGI:MGI:104593 more ... 13792537 PMID:21873635 GO_Central chemokine activity ISO RGD:735910 1624291 UniProtKB:P35411 (PMID:10415068), (PMID:21829356) RGD PMID:10415068 , PMID:21829356 chemokine activity IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 chemokine activity IEA UniProtKB:O35188 , ensembl:ENSMUSP000000342301600115 GO_REF:0000107 Ensembl GO_REF:0000107 chemokine activity ISO RGD:731691 1624291 (MGI:MGI:892218, PMID:9177350) RGD MGI:MGI:892218 , PMID:9177350 CX3C chemokine receptor binding IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 CX3C chemokine receptor binding ISO RGD:735910 1624291 (PMID:10415068), (PMID:23125415) RGD PMID:10415068 , PMID:23125415 CX3C chemokine receptor binding ISS UniProtKB:P78423 1600115 GO_REF:0000024 UniProt GO_REF:0000024 CXCR1 chemokine receptor binding IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 CXCR1 chemokine receptor binding ISO RGD:735910 1624291 UniProtKB:Q9Z0D9 (PMID:10187784) RGD PMID:10187784 integrin binding ISO RGD:735910 1624291 (PMID:23125415) RGD PMID:23125415 integrin binding ISS UniProtKB:P78423 1600115 GO_REF:0000024 UniProt GO_REF:0000024 integrin binding IEA UniProtKB:P78423 , ensembl:ENSP000000060531600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein binding ISO RGD:735910 1624291 UniProtKB:P05106 more ... RGD PMID:23125415 more ...
Gene-Chemical Interaction Annotations
